Ozempic 0.25mg is a subcutaneous injectable prescription medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is indicated for the treatment of insufficiently controlled type 2 diabetes mellitus in adults to improve glycemic control and to reduce the risk of major adverse cardiovascular events in patients with established cardiovascular disease.

Dosage & Administration

• Dosage: Adhere strictly to the dosing schedule and administration instructions provided by your physician.
• Method: Subcutaneous injection into the abdomen, thigh, or upper arm.
• Site Rotation: Rotate injection sites with each weekly dose to minimize tissue irritation.

Technical Specification

• Form: Clear, colorless, isotonic solution for injection.
• Active Ingredient: Semaglutide
• Delivery System: Multi-dose pre-filled pen designed for 4 doses.

Ingredient Functionality

• Semaglutide: Acts as a GLP-1 receptor agonist that increases insulin secretion in a glucose-dependent manner, decreases inappropriate glucagon secretion, and slows gastric emptying.
• Disodium Phosphate Dihydrate: Functions as a pH stabilizer to ensure the formulation remains isotonic with human plasma.
• Propylene Glycol: Utilized as a solvent and stabilizer within the aqueous delivery vehicle.

Safety & Storage

• Refrigeration: Store at 2°C to 8°C prior to first use. Do not freeze.
• Room Temperature: After first use, the pen may be stored for up to 6 weeks at room temperature (below 30°C) or in a refrigerator.
• Light Protection: Keep the pen cap on when not in use to protect the solution from light degradation.
• Visual Inspection: Solution must be clear and colorless to slightly yellow; discard if particles or cloudiness are present.